Veracyte | VCYT - Net Income

Stock Price
32.67
Daily Change
0.52 1.62%
Monthly
-2.10%
Yearly
0.15%
Q2 Forecast
31.28

Veracyte reported $41.15M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agenus USD -10.63M 74.49M Dec/2025
Agilent USD 305M 129M Dec/2025
Anika Therapeutics USD 292K 2.62M Dec/2025
Arrowhead Research USD 30.81M 54.56M Dec/2025
Bruker USD 26M 88.4M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Illumina USD 334M 184M Dec/2025
Karyopharm Therapeutics USD -102.2M 71.42M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Ligand Pharmaceuticals USD 117.27M 112.43M Sep/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
Rigel Pharmaceuticals USD 12.42M 13.45M Sep/2024
Roche Holding CHF 5.47B 1.76B Dec/2025
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Siemens EUR 2.03B 411M Dec/2025
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Veracyte USD 41.15M 22.01M Dec/2025
Waters USD 225.21M 76.29M Dec/2025